Aura 2016 Supplementary data

Table S4.25 Salmonella species (typhoidal) resistance (blood culture isolates), 2014

Antimicrobial	Blood, % resistance (n)
Ampicillin	2.3 (43)
Amoxicillin–clavulanate	0.0 (25)
Ticarcillin–clavulanate	0.0 (26)
Piperacillin–tazobactam	0.0 (21)
Cefazolin	0.0 (22)
Ceftriaxone	0.0 (44)
Ceftazidime	0.0 (26)
Cefepime	0.0 (26)
Trimethoprim	0.0 (25)
Trimethoprim–sulfamethoxazole	3.3 (30)
Gentamicin	0.0 (26)
Tobramycin	0.0 (26)
Amikacin	0.0 (26)
Ciprofloxacin	14.6 (41)
Norfloxacin	65.4 (26)
Nitrofurantoin	0.0 (26)
Meropenem	0.0 (26)

Sources: OrgTRx (Queensland); AGAR (national); SNP (Queensland and northern New South Wales)

Table S4.26 Salmonella species (nontyphoidal) resistance, by clinical setting, 2014

Antimicrobial	Public hospitals, % resistance (n)	Public hospitals and health services, % resistance (n)	Private hospitals, % resistance (n)	Community, % resistance (n)	Residential aged care facilities, % resistance (n)
Ampicillin	8.9 (90)	5.0 (1111)	15.1 (146)	8.8 (1358)	0.0 (11)
Amoxicillin–clavulanate	0.0 (88)	na	na	1.9 (52)	na
Ticarcillin–clavulanate	5.6 (89)	na	na	na	na
Piperacillin–tazobactam	0.0 (90)	na	na	na	na
Cefazolin	2.0 (49)	na	na	na	na
Ceftriaxone	1.1 (90)	0.8 (1077)	0.0 (11)	na	na
Ceftazidime	1.1 (90)	na	na	na	na
Cefepime	1.1 (90)	na	na	na	na
Trimethoprim	5.6 (90)	na	na	3.8 (52)	0.0 (4)
Trimethoprim–sulfamethoxazole	5.6 (90)	na	2.9 (139)	4.4 (1310)	0.0 (7)
Gentamicin	0.0 (90)	na	na	na	na
Tobramycin	0.0 (90)	na	na	na	na
Amikacin	0.0 (90)	na	na	na	na
Ciprofloxacin	0.0 (90)	0.4 (1059)	0.0 (10)	na	na
Norfloxacin	11.1 (90)	1.4 (1016)	1.7 (120)	0.0 (52)	0.0 (11)
Nitrofurantoin	8.9 (90)	na	na	na	na
Meropenem	0.0 (90)	na	na	na	na

na = not available (either not tested or tested against an inadequate number of isolates)

Sources: AGAR (public and private hospitals); OrgTRx, Queensland (public hospitals and health services); SNP (private hospitals, community and residential aged care facilities)